Portfolio company
Vaxess
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company develops microarray patches to provide needle-free, self-administered therapy delivery for patients requiring injectable treatments such as GLP-1.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Terrestrial Bio
This company develops needle-free, temperature-stable microarray patches for the self-administration of therapeutics and vaccines to improve patient access and outcomes.
Micron Biomedical
This company develops dissolvable microarray patches for needle-free delivery of vaccines and therapeutics to patients in military and global health sectors.
Transdermal Diagnostics
This company develops needle-free, continuous glucose monitoring patches for people living with diabetes and prediabetes to manage blood sugar levels non-invasively.
Anodyne Nanotech
The company develops microneedle patches for the transdermal delivery of large-molecule medicines to patients with chronic conditions like obesity and sarcopenia.
Biolinq
This company develops wearable intradermal biosensor patches for people with diabetes to continuously monitor glucose levels and metabolic health biomarkers.
Jurata
This company develops thermostable thin-film formulations for vaccines and biologics, enabling needle-free administration and room-temperature storage for pharmaceutical manufacturers and healthcare providers.
NanoPass Technologies
This company develops microneedle-based intradermal delivery devices for healthcare providers and pharmaceutical companies to administer vaccines, drugs and aesthetic treatments.
Helix Nanotechnologies
This deep-tech company develops an mRNA platform to create vaccines and therapies for biotechnology organisations and patients with complex immune requirements.
